scholarly journals Improved survival with double platinum therapy transcatheter arterial infusion using cisplatin and transcatheter arterial chemoembolization using miriplatin for BCLC-B hepatocellular carcinoma

2016 ◽  
Vol 5 (5) ◽  
pp. 511-516
Author(s):  
Toru Ishikawa ◽  
Satoshi Abe ◽  
Takayuki Watanabe ◽  
Yujiro Nozawa ◽  
Tomoe Sano ◽  
...  
2020 ◽  
Vol 10 (13) ◽  
pp. 4607
Author(s):  
Kazuhiro Nouso ◽  
Takamasa Ohki ◽  
Tatsuya Yamashita ◽  
Haruyuki Takaki ◽  
Chien-Au Liu ◽  
...  

Many guidelines and standard therapies have been published for the treatment of hepatocellular carcinoma (HCC). Multiple options for the treatment of early to intermediate-stage HCC have resulted in several differences between the guidelines. In addition, more than a few non-standard therapies have been used in a real-world clinical setting. Radiofrequency ablation or chemotherapy, including hepatic arterial infusion chemotherapy and molecular target agents, are sometimes selected for the treatment of intermediate HCC, whereas in many guidelines, the recommended therapy for these patients is transcatheter arterial chemoembolization. The present status of these topics is reviewed and summarized.


2002 ◽  
Vol 46 (3) ◽  
pp. 229
Author(s):  
Seung Hun Ryu ◽  
Hyung Jin Shim ◽  
Byung Kook Kwak ◽  
Gi Hyun Kim ◽  
Hwa Yeon Lee ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document